Company to Showcase its Innovate Gene Therapy Programs in Oncology and Diabetes
AUSTIN, Texas, March 8, 2023 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ:GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the Company's participation in the following upcoming investor and industry conferences to be held in March 2023.
Read more at prnewswire.com